We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+0.64%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.26B
AUM Growth
-$618M
(-11%)
Cap. Flow
-$615M
Cap. Flow
% of AUM
-11.69%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
928
New
151
Increased
197
Reduced
368
Closed
132
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$43.8M |
| 2 |
UnitedHealth
UNH
|
+$42.1M |
| 3 |
Verizon
VZ
|
+$32.3M |
| 4 |
Comcast
CMCSA
|
+$29.1M |
| 5 |
Citigroup
C
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$70.8M |
| 2 |
Apple
AAPL
|
+$38.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$36.3M |
| 4 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$31.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.72% |
| 2 | Healthcare | 17.4% |
| 3 | Technology | 16.88% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Nektar Therapeutics
NKTR
$2.39B
| $3.49M | 0.07% |
18,583
+11,466
| +161% | +$1.97M |
|
277
Quad
QUAD
$430M
| $3.43M | 0.07% |
185,470
+16,600
| +10% | +$350K |
|
278
MetLife
MET
$61B
| $3.43M | 0.07% |
68,745
-976
| -1% | -$46.2K |
|
|
FCB
279
DELISTED
FCB Financial Holdings, Inc.
FCB
| $3.39M | 0.06% |
106,555
+29,540
| +38% | +$844K |
|
|
PDM
280
Piedmont Realty Trust
PDM
$1.22B
| $3.39M | 0.06% |
192,517
-1,300
| -0.7% | -$23.1K |
|
281
Werner Enterprises
WERN
$2.54B
| $3.38M | 0.06% |
128,923
-23,440
| -15% | -$666K |
|
282
Reinsurance Group of America
RGA
$15.7B
| $3.37M | 0.06% |
35,510
-3,600
| -9% | -$339K |
|
|
MANT
283
DELISTED
Mantech International Corp
MANT
| $3.37M | 0.06% |
116,124
+280
| +0.2% | +$8.47K |
|
|
TCF
284
DELISTED
TCF Financial Corporation
TCF
| $3.37M | 0.06% |
202,773
-270,760
| -57% | -$4.35M |
|
285
Benchmark Electronics
BHE
$2.91B
| $3.36M | 0.06% |
154,313
+49,693
| +47% | +$1.18M |
|
286
NextEra Energy
NEE
$187B
| $3.32M | 0.06% |
+135,520
| New | +$3.44M |
|
|
AVG
287
DELISTED
AVG Technologies N.V.
AVG
| $3.31M | 0.06% |
121,632
-15,378
| -11% | -$375K |
|
288
Avnet
AVT
$7.33B
| $3.29M | 0.06% |
80,125
+57,405
| +253% | +$2.53M |
|
289
AMC Entertainment Holdings
AMC
$2.03B
| $3.27M | 0.06% |
10,666
+607
| +6% | +$187K |
|
290
Caleres
CAL
$396M
| $3.24M | 0.06% |
101,857
-30,910
| -23% | -$965K |
|
|
STJ
291
DELISTED
St Jude Medical
STJ
| $3.22M | 0.06% |
44,110
-10,700
| -20% | -$773K |
|
292
Brunswick
BC
$5.19B
| $3.21M | 0.06% |
63,100
+28,280
| +81% | +$1.48M |
|
293
Prosperity Bancshares
PB
$8.77B
| $3.16M | 0.06% |
54,660
-1,200
| -2% | -$65.3K |
|
|
AL
294
DELISTED
Air Lease Corp
AL
| $3.15M | 0.06% |
92,937
+68,137
| +275% | +$2.58M |
|
|
SONC
295
DELISTED
Sonic Corp
SONC
| $3.14M | 0.06% |
109,150
-18,680
| -15% | -$574K |
|
296
Zimmer Biomet
ZBH
$17.7B
| $3.12M | 0.06% |
29,458
| – | – |
|
297
Bio-Techne
TECH
$11.2B
| $3.12M | 0.06% |
126,800
-17,560
| -12% | -$438K |
|
298
Invesco Mortgage Capital
IVR
$776M
| $3.1M | 0.06% |
+21,644
| New | +$3.39M |
|
|
VRE
299
DELISTED
Veris Residential
VRE
| $3.1M | 0.06% |
168,100
| – | – |
|
300
Graphic Packaging
GPK
$3.26B
| $3.08M | 0.06% |
220,790
-56,050
| -20% | -$804K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2015 Portfolio in Review
As of Q2 2015, Jacobs Levy Equity Management held 928 positions worth $5.26B, down 11% from $5.88B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jacobs Levy Equity Management withdrew a net $615M in Q2 2015, closing 132 positions and reducing 368 holdings. Its most notable exit was BROADCOM CORP CL-A, an estimated $31.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jacobs Levy Equity Management opened a new position in UnitedHealth worth $43.4M.
- Jacobs Levy Equity Management's largest Q2 2015 buy was UnitedHealth: 355,991 shares worth $43.4M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q2 2015, an estimated $43.8M increase.
- Jacobs Levy Equity Management's biggest Q2 2015 reduction was Microsoft, cutting an estimated $70.8M.
- Jacobs Levy Equity Management fully exited BROADCOM CORP CL-A in Q2 2015, selling an estimated $31.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 14% of its $5.26B portfolio in Q2 2015.
- Jacobs Levy Equity Management opened 151 new positions and closed 132 in Q2 2015.
- Jacobs Levy Equity Management's portfolio value fell 11% quarter-over-quarter to $5.26B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2015, filed 14 Aug 2015.